California Public Employees Retirement System’s Revance Therapeutics, Inc. RVNC Stock Holding History

California Public Employees Retirement System’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-113,060	Closed	-$3.16M	–	3020
2021 Q1	$3.16M	Sell	113,060 -24,277	-18%	-$671K	﹤0.01%	1718
2020 Q4	$3.89M	Sell	137,337 -6,798	-5%	-$176K	﹤0.01%	1570
2020 Q3	$3.62M	Buy	144,135 +16,853	+13%	+$442K	﹤0.01%	1462
2020 Q2	$3.11M	Buy	127,282 +33,282	+35%	+$657K	﹤0.01%	1522
2020 Q1	$1.39M	Buy	94,000 +5,900	+7%	+$122K	﹤0.01%	1805
2019 Q4	$1.43M	Buy	88,100 +19,865	+29%	+$308K	﹤0.01%	2193
2019 Q3	$887K	Buy	68,235 +19,135	+39%	+$234K	﹤0.01%	2335
2019 Q2	$637K	Sell	49,100 -2,655	-5%	-$33.5K	﹤0.01%	2422
2019 Q1	$816K	Hold	51,755	–	–	﹤0.01%	2332
2018 Q4	$1.04M	Buy	+51,755	New	+$1.14M	﹤0.01%	2178
2016 Q1	–	Sell	-10,600	Closed	-$362K	–	3608
2015 Q4	$362K	Buy	+10,600	New	+$367K	﹤0.01%	2948
2014 Q4	–	Sell	-15,769	Closed	-$305K	–	3837
2014 Q3	$305K	Buy	15,769 +5,698	+57%	+$149K	﹤0.01%	3218
2014 Q2	$342K	Buy	+10,071	New	+$316K	﹤0.01%	3194

Other funds holding RVNC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

California Public Employees Retirement System's RVNC Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2021, closing a stake of 113,060 shares — an estimated $3.16M sold.

California Public Employees Retirement System first reported a position in RVNC in Q2 2014 and held it in 13 quarters. The position peaked at $3.89M in Q4 2020. 161 funds tracked by Wall St. Rank hold RVNC as of Q2 2021.

California Public Employees Retirement System reported no remaining Revance Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
California Public Employees Retirement System sold 113,060 Revance Therapeutics, Inc. shares in Q2 2021, an estimated $3.16M.
California Public Employees Retirement System first reported a position in Revance Therapeutics, Inc. in Q2 2014 and held it in 13 quarters.
California Public Employees Retirement System's Revance Therapeutics, Inc. position peaked at $3.89M in Q4 2020.
161 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.